Jianwen Huang is a partner at King & Wood Mallesons (KWM). She is the director-in-chief of KWM Belt & Road Center for International Cooperation and Facilitation (BRCICF) and a leading partner in KWM’s healthcare group. Ms Huang specialises in investments (including inbound and outbound investment), M&A (including domestic and cross-border M&A), and general corporate matters. Ms Huang acts for clients from varied industry backgrounds for their M&A transactions and general corporate matters. The industries include pharmaceutical, medical, medical devices, food (including health food), agricultural products, cosmetics, direct marketing, clean energy (solar, wind and nuclear energy), machinery manufacturing, aerospace, mining, ports, and telecommunications, etc.
Ms Huang has accumulated extensive experience in investment and M&A, and provided legal services to many multinational companies (including Fortune 500 companies), domestic companies, and state-owned enterprises (SOEs) for their domestic investment and M&A projects. Her legal services include complete architectural design of the investment and M&A transactions, due diligence, drafting and modifying transaction documents, negotiation, and assisting liaison with the government and assisting in the assessment and the approval of the governmental process. Ms Huang’s many years of professional experience has helped her familiarise herself with different operation models, management models and philosophies of companies. This helps her to provide the best advice to her clients for their M&A deals. One of her representative matter is acting as GE’s counsel with respect to Chinese law in GE’s acquisition of Alstom’s power and grid business, which is the biggest M&A deal in 2015 in the industry and the biggest industrial investment GE has ever made.
As the leading partner of the KWM healthcare group, Ms Huang has acted for a number of domestic and multinational pharmaceutical companies, medical device companies and medical institution investors in relation to setting up, investment, mergers, daily operations and obtaining all types of relevant approvals. She has also assisted in liaising with the National Medical Products Administration and other authorities. She has served as an expert witness regarding Chinese legal matters and provided opinions on Chinese laws in several overseas cases involving health food.
Ms Huang is recognised as one of the ‘Top 1000 Lawyers of Foreign-Related Affairs’ by the Ministry of Justice of PRC. She is identified as a leading individual in the field of Healthcare & Life Sciences in 2019 by The Legal 500. She is identified as a Tier 1 lawyer in the field of Healthcare & Life Sciences in 2018 and 2019 by Legal Band. She was identified as a highly recommended lawyer in the field of healthcare and life sciences in 2018 by The Legal 500 and was identified as a highly recommended lawyer in the field of corporate and M&A in 2015 by The Legal 500. She was also recognised as one of the 2017 A-List China’s Top 100 lawyers by China Business Law Journal. Moreover, she was recognised as one of the Top 10 Lawyers Returning to China after Overseas Study by the Beijing Bar Association in 2011. She has also received multiple KWM awards, including the 2015 Outstanding Cross-border Cooperation of the Year; the 2012 Outstanding Partner of the Year Award; the 2010 Outstanding Partner Award; and the 2006 Outstanding Lawyer Award.
Ms Huang has been qualified to practise law in China since 1996 and her working languages are Chinese and English.
Ms Huang joined KWM in 2003. Prior to joining KWM, she was a lecturer (corporate law) at Beijing Economics and Trade University School of Law.
Ms Huang obtained her LL.M. from New York University School of Law in the United States, and her Master of Philosophy in Law (M.Phil.) from City University of Hong Kong. She was also a visiting scholar at Harvard Law School.
Get unlimited access to all The Law Reviews content